These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 21680189)
21. An in silico analysis of the binding modes and binding affinities of small molecule modulators of PDZ-peptide interactions. Tiwari G; Mohanty D PLoS One; 2013; 8(8):e71340. PubMed ID: 23951139 [TBL] [Abstract][Full Text] [Related]
22. Importance of a Conserved Lys/Arg Residue for Ligand/PDZ Domain Interactions as Examined by Protein Semisynthesis. Pedersen SW; Moran GE; Sereikaitė V; Haugaard-Kedström LM; Strømgaard K Chembiochem; 2016 Oct; 17(20):1936-1944. PubMed ID: 27472651 [TBL] [Abstract][Full Text] [Related]
23. Theoretical models of interactions between buspirone analogues and 5-HT1A and 5-HT2A serotonin receptor subtypes. Bronowska A; Sylte I; Edvardsen Ø; Østensen R; Leś A; Chilmonczyk Z Acta Pol Pharm; 2000 Nov; 57 Suppl():40-5. PubMed ID: 11293260 [TBL] [Abstract][Full Text] [Related]
25. Crystal structure of the second PDZ domain of SAP97 in complex with a GluR-A C-terminal peptide. von Ossowski I; Oksanen E; von Ossowski L; Cai C; Sundberg M; Goldman A; Keinänen K FEBS J; 2006 Nov; 273(22):5219-29. PubMed ID: 17069616 [TBL] [Abstract][Full Text] [Related]
26. Design, synthesis, and characterization of fatty acid derivatives of a dimeric peptide-based postsynaptic density-95 (PSD-95) inhibitor. Nissen KB; Andersen JJ; Haugaard-Kedström LM; Bach A; Strømgaard K J Med Chem; 2015 Feb; 58(3):1575-80. PubMed ID: 25590984 [TBL] [Abstract][Full Text] [Related]
27. Biochemical investigations of the mechanism of action of small molecules ZL006 and IC87201 as potential inhibitors of the nNOS-PDZ/PSD-95-PDZ interactions. Bach A; Pedersen SW; Dorr LA; Vallon G; Ripoche I; Ducki S; Lian LY Sci Rep; 2015 Jul; 5():12157. PubMed ID: 26177569 [TBL] [Abstract][Full Text] [Related]
28. Computer-aided design of a PDZ domain to recognize new target sequences. Reina J; Lacroix E; Hobson SD; Fernandez-Ballester G; Rybin V; Schwab MS; Serrano L; Gonzalez C Nat Struct Biol; 2002 Aug; 9(8):621-7. PubMed ID: 12080331 [TBL] [Abstract][Full Text] [Related]
33. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus. Almaula N; Ebersole BJ; Ballesteros JA; Weinstein H; Sealfon SC Mol Pharmacol; 1996 Jul; 50(1):34-42. PubMed ID: 8700116 [TBL] [Abstract][Full Text] [Related]
34. SH3 domains and drug design: ligands, structure, and biological function. Dalgarno DC; Botfield MC; Rickles RJ Biopolymers; 1997; 43(5):383-400. PubMed ID: 9566119 [TBL] [Abstract][Full Text] [Related]
35. Design and synthesis of Rho kinase inhibitors (II). Iwakubo M; Takami A; Okada Y; Kawata T; Tagami Y; Ohashi H; Sato M; Sugiyama T; Fukushima K; Iijima H Bioorg Med Chem; 2007 Jan; 15(1):350-64. PubMed ID: 17046269 [TBL] [Abstract][Full Text] [Related]
36. Unexpected modes of PDZ domain scaffolding revealed by structure of nNOS-syntrophin complex. Hillier BJ; Christopherson KS; Prehoda KE; Bredt DS; Lim WA Science; 1999 Apr; 284(5415):812-5. PubMed ID: 10221915 [TBL] [Abstract][Full Text] [Related]
37. Low Basicity as a Characteristic for Atypical Ligands of Serotonin Receptor 5-HT2. Podlewska S; Bugno R; Lacivita E; Leopoldo M; Bojarski AJ; Handzlik J Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494248 [TBL] [Abstract][Full Text] [Related]
38. A flexible docking procedure for the exploration of peptide binding selectivity to known structures and homology models of PDZ domains. Niv MY; Weinstein H J Am Chem Soc; 2005 Oct; 127(40):14072-9. PubMed ID: 16201829 [TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, and evaluation of linear and cyclic peptide ligands for PDZ10 of the multi-PDZ domain protein MUPP1. Sharma SC; Rupasinghe CN; Parisien RB; Spaller MR Biochemistry; 2007 Nov; 46(44):12709-20. PubMed ID: 17939682 [TBL] [Abstract][Full Text] [Related]
40. Thermodynamics of binding of heterobidentate ligands consisting of spacer-connected acarbose and beta-cyclodextrin to the catalytic and starch-binding domains of glucoamylase from Aspergillus niger shows that the catalytic and starch-binding sites are in close proximity in space. Sigurskjold BW; Christensen T; Payre N; Cottaz S; Driguez H; Svensson B Biochemistry; 1998 Jul; 37(29):10446-52. PubMed ID: 9671514 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]